Friday, November 22, 2024
If there is one topic that scientists disagree strongly about in the field of medicine, it is the so-called amyloid hypothesis. This theory, believed by many scientists, holds that the protein amyloid-β accumulates into toxic deposits as Alzheimer’s disease progresses, ultimately causing dementia. However, others think that amyloid is associated with the problem, but it […]
Finding winners in the pharmaceutical sector is not an easy process. But it is potentially quite lucrative. For the pharmaceutical companies themselves, the current environment for success is reminiscent of the Greek myth surrounding Sisyphus, whom the gods condemned to repeatedly roll a boulder up a hill—only to have it roll down again once he […]
America has a history of welcoming refugees from foreign shores. And now Wall Street is doing its part by welcoming a refugee from the United Kingdom. Unlike the U.S. market, the U.K. market has never been very fond of technology stocks, including biotechnology companies. Their valuations—and the levels of interest the attract—are usually low. That’s […]
Few sectors can withstand the economic headwinds that come during periods of economic upheaval, including recession and inflation. Recession stocks are sought out by retail and institutional investors alike. But one sector that can thrive is food—people will always need to eat. Another area largely insulated from market turmoil is the pharmaceutical sector. Prescription drugs […]
Just when you thought it was safe to go outside, monkeypox pops up. “Doctors warned that numbers will rise significantly as the virus spreads through Europe and as far as the U.S., Canada, and Australia. Spain now has the highest number of infections, outside places in Africa where the virus is endemic, with more than […]
There is multi, multi, multi-billions of dollars earmarked by the drug companies. Why? They want to acquire up-and-coming competitors and those with valuable patents they can exploit. For about 7 years, the drug industry has drastically underperformed the S&P 500. However, look over my shoulder and see how this narrative could change very soon. Every […]
Vaccine makers’ stocks are soaring. Pfizer (PFE) was up $1.75 earlier this week, at $52.00 BioNTech (BNTX) was up about $17, at $152.40 Moderna (MRNA)was up $15, at $153.25 This is due in part to news that China is battling another wave of coronavirus infections. Millions of people across China are on lockdown. Schools in […]
Investing in biotech stocks often comes with huge risks and rewards, as a company is dependent on its pipeline and royalty payments. It can also take years to develop a treatment or drug, which can burn through cashflow until approved by the Food and Drug Administration. One such company that remains unprofitable but has a […]
Cassava Sciences (SAVA) has been in the news throughout 2021 as the company continues its efforts in bringing its lead drug, Simufilam—an experimental Alzheimer’s treatment currently in Phase 3 trials—to market. Aside from Simufilam, the company’s product portfolio also includes an investigational blood-based diagnostic to detect and monitor the progression of Alzheimer’s disease, called SavaDx. […]
Most of us are exhausted from pandemic news. Unfortunately, it’s not over just yet. All as the number of Omicron cases nearly doubled over the last few days. In fact, reports CNBC: “The omicron variant is raging across the world as the winter holiday season approaches. The strain has been found through testing in 43 […]
